DK0839154T3 - Biologiske aktive peptider og præparater samt anvendelse deraf - Google Patents

Biologiske aktive peptider og præparater samt anvendelse deraf

Info

Publication number
DK0839154T3
DK0839154T3 DK96910116T DK96910116T DK0839154T3 DK 0839154 T3 DK0839154 T3 DK 0839154T3 DK 96910116 T DK96910116 T DK 96910116T DK 96910116 T DK96910116 T DK 96910116T DK 0839154 T3 DK0839154 T3 DK 0839154T3
Authority
DK
Denmark
Prior art keywords
preparations
biologically active
active peptides
derivatives
geodiamolide
Prior art date
Application number
DK96910116T
Other languages
English (en)
Inventor
Raymond Andersen
John Coleman
Silva Dilip De
Fangming Kong
Edward Piers
Debra Wallace
Michel Roberge
Theresa Allen
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of DK0839154T3 publication Critical patent/DK0839154T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK96910116T 1995-04-20 1996-04-22 Biologiske aktive peptider og præparater samt anvendelse deraf DK0839154T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9508195.6A GB9508195D0 (en) 1995-04-20 1995-04-20 Novel biologically active compounds and compositions,their use and derivation
PCT/GB1996/000942 WO1996033211A1 (en) 1995-04-20 1996-04-22 Biologically active peptides and compositions, their use

Publications (1)

Publication Number Publication Date
DK0839154T3 true DK0839154T3 (da) 2004-04-19

Family

ID=10773352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96910116T DK0839154T3 (da) 1995-04-20 1996-04-22 Biologiske aktive peptider og præparater samt anvendelse deraf

Country Status (12)

Country Link
US (4) US6153590A (da)
EP (1) EP0839154B1 (da)
JP (2) JP4008493B2 (da)
AT (1) ATE256698T1 (da)
AU (1) AU5341696A (da)
CA (1) CA2220021C (da)
DE (1) DE69631141T2 (da)
DK (1) DK0839154T3 (da)
ES (1) ES2213173T3 (da)
GB (1) GB9508195D0 (da)
PT (1) PT839154E (da)
WO (1) WO1996033211A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2225325A1 (en) * 1997-12-19 1999-06-19 The University Of British Columbia Hemiasterlin analogs
US6395897B1 (en) 1999-03-02 2002-05-28 Boehringer Ingelheim Pharmaceuticals, Inc. Nitrile compounds useful as reversible inhibitors of #9 cathepsin 5
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
IL155781A0 (en) * 2000-11-06 2003-12-23 Pharma Mar Sa Effective antitumor treatments
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
US7064211B2 (en) 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
AU2003228354B8 (en) * 2002-03-22 2010-03-04 Eisai R&D Management Co., Ltd. Hemiasterlin derivatives and uses thereof in the treatment of cancer
US20040121965A1 (en) * 2002-09-20 2004-06-24 Wyeth Holdings Corporation Method of treating resistant tumors
KR20050054951A (ko) 2002-09-20 2005-06-10 와이어쓰 홀딩스 코포레이션 튜불린 억제제의 합성에 유용한 중간체의 합성방법
PT1558354E (pt) * 2002-10-30 2010-04-20 Merck Sharp & Dohme Utilização de aminas, aminoácidos ou ésteres de aminoácidos como modificadores da fase móvel em cromatografia
US20070026478A1 (en) * 2002-11-21 2007-02-01 Wyeth Hemiasterlin affinity probes and their uses
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
US7390910B2 (en) * 2003-08-08 2008-06-24 Wyeth Compounds for treating tumors
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
WO2005049031A1 (en) * 2003-11-13 2005-06-02 Pharma Mar, S.A.U. Combination
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
JP2007511509A (ja) * 2003-11-14 2007-05-10 ファルマ・マール・ソシエダード・アノニマ Ｅｔ−７４３およびパクリタキセルの使用を含むガンの併用療法
US20080293725A1 (en) * 2004-07-09 2008-11-27 Rafael Rosell Costa Prognostic Molecular Markers
AU2005288696A1 (en) * 2004-09-28 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
BRPI0518250A2 (pt) * 2004-10-26 2008-11-11 Pharma Mar Sa tratamentos anticÂncer
NZ554761A (en) * 2004-10-29 2010-01-29 Pharma Mar Sa Formulations comprising ecteinascidin and a disaccharide
JP2008522624A (ja) * 2004-12-09 2008-07-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘミアスタリン（ｈｅｍｉａｓｔｅｒｌｉｎ）アナログを使用する癌治療におけるチューブリンのアイソタイプのスクリーニング
CN101189013A (zh) * 2005-05-05 2008-05-28 卫材株式会社 (2e,4s)-4-[(n-{[(2r)-1-异丙基哌啶-2-基]-羰基}-3-甲基-l-缬氨酰基)(甲基)氨基]-2,5-二甲基己-2-烯酸的非溶剂化和主客体溶剂化晶形及其药学用途
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
JP2010520855A (ja) * 2007-01-31 2010-06-17 アフィーマックス・インコーポレイテッド 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー
US20100267732A1 (en) * 2007-10-19 2010-10-21 Pharma Mar, S.A. Prognostic Molecular Markers for ET-743 Treatment
ES2523580T3 (es) 2008-01-11 2014-11-27 Albany Molecular Research, Inc. Piridoindoles substituidos con (1-Azinona)
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
JP2012532144A (ja) 2009-07-01 2012-12-13 アルバニー モレキュラー リサーチ， インコーポレイテッド アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
US8697700B2 (en) 2010-12-21 2014-04-15 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
CN103570603A (zh) * 2012-07-19 2014-02-12 杭州中肽生化有限公司 哈米特林的一种合成新方法
MX368258B (es) 2013-03-15 2019-09-25 Zymeworks Inc Compuestos citotoxicos y antimitoticos y metodos de uso de los mismos.
CA2935064C (en) 2013-12-27 2023-06-27 Zymeworks Inc. Var2csa-drug conjugates
CN106255513B (zh) 2013-12-27 2022-01-14 酵活有限公司 用于药物偶联物的含磺酰胺连接系统
IL287645B2 (en) 2014-09-17 2024-04-01 Zymeworks Bc Inc Cytotoxic and anti-mitotic compounds and methods for their use
EP3370518B1 (en) 2015-10-14 2023-08-23 X-Therma, Inc. Compositions and methods for reducing ice crystal formation
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
CA3072153A1 (en) * 2017-08-10 2019-02-14 Sumitomo Dainippon Pharma Co., Ltd. Antibody-drug conjugates including hemiasterlin derivative
EP3666788A4 (en) * 2017-08-10 2021-05-05 Sumitomo Dainippon Pharma Co., Ltd. HEMIASTERLIN DERIVATIVES AND ANTIBODY-ACTIVE INGREDIENT CONJUGATES CONTAINING THESE
WO2020166613A1 (ja) * 2019-02-13 2020-08-20 大日本住友製薬株式会社 多能性幹細胞の除去剤
JP7560255B2 (ja) * 2019-02-13 2024-10-02 住友ファーマ株式会社 ヘミアスタリン誘導体を含む抗体薬物複合体を含有する医薬
CA3127312A1 (en) 2019-02-13 2020-08-20 Sumitomo Dainippon Pharma Co., Ltd. Hemiasterlin derivative having cysteine residue

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2904512A1 (de) * 1979-02-07 1980-08-28 Troponwerke Gmbh & Co Kg Dehydropeptide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
US4820691A (en) 1987-06-24 1989-04-11 E. R. Squibb & Sons, Inc. Amino acid 1,2-diketo derivatives as renin inhibitors
US5081225A (en) * 1989-02-09 1992-01-14 E. R. Squibb & Sons, Inc. Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum
US5340802A (en) * 1989-06-30 1994-08-23 Abbott Laboratories Peptide analog type-B CCK receptor ligands
WO1991004040A1 (en) * 1989-09-15 1991-04-04 Biomeasure, Inc. Treatment of colon cancer
FR2681075B1 (fr) * 1991-09-05 1994-09-16 Commissariat Energie Atomique Preparation enzymatique purifiee issue de chromobacterium violaceum, son procede d'obtention et son application a la production d'alpha,beta-dehydrotryptophanyl-peptides.
WO1993017701A1 (en) * 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5661175A (en) * 1995-06-20 1997-08-26 Kashman; Yoel Hemiasterlin and geodiamolide TA
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof

Also Published As

Publication number Publication date
US20050171137A1 (en) 2005-08-04
DE69631141T2 (de) 2004-09-30
CA2220021C (en) 2012-06-26
JP4006466B2 (ja) 2007-11-14
CA2220021A1 (en) 1996-10-24
PT839154E (pt) 2004-05-31
US6870028B1 (en) 2005-03-22
GB9508195D0 (en) 1995-06-07
DE69631141D1 (de) 2004-01-29
ES2213173T3 (es) 2004-08-16
US6153590A (en) 2000-11-28
EP0839154A1 (en) 1998-05-06
JPH11505211A (ja) 1999-05-18
ATE256698T1 (de) 2004-01-15
EP0839154B1 (en) 2003-12-17
JP4008493B2 (ja) 2007-11-14
US7410951B2 (en) 2008-08-12
US20090088573A1 (en) 2009-04-02
AU5341696A (en) 1996-11-07
US7772397B2 (en) 2010-08-10
JP2007031441A (ja) 2007-02-08
WO1996033211A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
DK0839154T3 (da) Biologiske aktive peptider og præparater samt anvendelse deraf
DE59914996D1 (en) Heterocyclisch substituierte amide als calpainhemmer
FI970810A0 (fi) Ionipolymeerejä sisältäviä biologisesti aktiivisia anioneja
ATE354655T1 (de) Humane antikörper gegen ctla-4 und deren verwendungen
ES2157994T3 (es) Inhibidores tetra y pentapeptidos sustituidos de la proteina farnesiltransferasa.
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
TR199800012T1 (xx) Piroloprimidinler ve preparasyon i�in tatbikler.
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
ATE404667T1 (de) Chromatin-regulatorgene
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
HUP9800731A2 (hu) Eljárás ivarsejt osztódás stimulálására
AR021695A1 (es) 4,5-pirazinoxindoles, composicion farmaceutica y uso
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
TR200101476T2 (tr) N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması
TR199800904T2 (xx) Yeni kinoksalindiyon t�revleri'nin �retimi ve ila�larda kullan�m�
ATE271878T1 (de) Verwendung von protein h als zytostattischer wirkstoff